Ifp Advisors, Inc Lyra Therapeutics, Inc. Transaction History

Ifp Advisors, Inc

  • $3.28 Billion
  • Q2 2025

A detailed history of Ifp Advisors, Inc transactions in Lyra Therapeutics, Inc. stock. As of the latest transaction made, Ifp Advisors, Inc holds 300 shares of LYRA stock, worth $2,025. This represents 0.0% of its overall portfolio holdings.

Number of Shares
300
Holding current value
$2,025
% of portfolio
0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Jul 24, 2025
BUY
$0.08 - $29.89 $24 - $8,967
300 New
300 $2,000

Others Institutions Holding LYRA

# of Institutions
8
Shares Held
3.09M
Call Options Held
0
Put Options Held
0
View Full List

About Lyra Therapeutics, Inc.

LYRA Quotes by TradingView
  • Ticker LYRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 31,826,400
  • Market Cap $215M
  • Description
  • Lyra Therapeutics, Inc., a clinical-stage therapeutics company, focuses on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose, and throat diseases. It's XTreo technology platform is designed to deliver medicines directly to the affected tissue for sustained...
More about LYRA
Track This Portfolio

Track Ifp Advisors, Inc Portfolio

Follow Ifp Advisors, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ifp Advisors, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ifp Advisors, Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email